- Net loss narrowed to $40.7M ($0.62/share) vs. $61.9M ($1.20/share) in Q3 prior year.
- Total revenues dropped sharply to ~$9.2M compared to $29.8M in the prior-year period.
- Cash and equivalents stood at $95.8M as of Sep 30, with pivotal wet AMD topline data due in Q4.
Signal #144229 · SEC 8-K
$RGNX SEC Filing Alert & Real-Time AI Stock Impact Analysis
Public T0 SEO entry. Full AI score & bullets unlock after 4 hours (VIP: instant).
FAQ: $RGNX filing catalyst
Why did $RGNX trigger an AI stock catalyst alert?
$RGNX triggered a Stock Catalyst AI alert on 2026-11-05 00:00:00 UTC for a SEC 8-K filing (AI Score: -1.0/10). Headline: REGENXBIO Reports Q3 Net Loss of $40.7M on Lower Revenues; Pipeline Milestones Reaffirmed. Key points: - Net loss narrowed to $40.7M ($0.62/share) vs. $61.9M ($1.20/share) in Q3 prior year. - Total revenues dropped sharply to ~$9.2M compared to $29.8M in the prior-year period. - Cash and equivalents stood at $95.8M as of Sep 30, with pivotal wet AMD topline data due in Q4.
How did $RGNX stock react after the SEC filing?
After the SEC 8-K for $RGNX, observed market reaction: T0 price $7.71. Past moves do not guarantee future results.
Where can I get real-time $RGNX SEC filing alerts?
Stock Catalyst AI pushes real-time SEC 8-K alerts for $RGNX via Telegram and the VIP Web Terminal from €10/month.